Form D filings in Maryland.
339 Form D notices were filed by issuers based in Maryland in Q2 2026 and Q3 2026, 260 new and 79 amendments. 92.6% claimed Rule 506(b) and 7.1% Rule 506(c).
- Notices
- 339
- Amendments
- 79
- Rule 506(c)
- 7.1%
- Pooled funds
- 57.8%
- Amount sold, new notices
- $2.38B
- Latest filing
- 2026-09-30
Latest notices
| Filed | Issuer | Industry | Type | Amount sold | Offering size | Exemptions |
|---|---|---|---|---|---|---|
| 2026-09-30 | Lumina at Eko LLC | Residential | D | $0 | $9.5M | Rule 506(c) |
| 2026-09-30 | SCP Opportunity CXXXV LP | Pooled Investment Fund | D | $4.4M | $10.0M | Rule 506(b) |
| 2026-09-29 | Knollwood Alpha Strategy IV LP | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1), 3(c)(7) |
| 2026-09-28 | Bristol Denville, LLC | Commercial | D/A | $665K | $8.6M | Rule 506(c) |
| 2026-09-24 | Oakley Investor LLC | Other Real Estate | D | $0 | Indefinite | Rule 506(b) |
| 2026-09-24 | Independent Access Partners UForce SPV, LLC | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-24 | Aromha, Inc. | Other Health Care | D | $75K | $75K | Rule 506(b) |
| 2026-09-24 | Seraxis Holdings, Inc. | Biotechnology | D | $10.0M | $10.0M | Rule 506(b) |
| 2026-09-23 | Uvantis Therapeutics, Inc. | Biotechnology | D | $100K | $5.0M | Rule 506(b) |
| 2026-09-23 | Phoenix Brain Wellness Inc. | Other Technology | D | $0 | $1.0M | Rule 506(b) |
| 2026-09-23 | Cambium Capital Retama LP | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1), 3(c)(7) |
| 2026-09-23 | Caro Real Estate Credit Fund, L.P. | Pooled Investment Fund | D/A | $262.1M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-23 | Brown Advisory Investors 2026 - HIG Infrastructure II (TE), LLLP | Pooled Investment Fund | D | $18.5M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-23 | Brown Advisory Investors 2026 - HIG Infrastructure II, LLLP | Pooled Investment Fund | D | $22.8M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-22 | JBS Touring LLC | Other | D | $2.9M | $4.0M | Rule 506(b) |
| 2026-09-22 | TP Investor LLC | Other Real Estate | D | $17.4M | Indefinite | Rule 506(b) |
| 2026-09-22 | LC Middletown Investor LLC | Other Real Estate | D | $4.1M | Indefinite | Rule 506(b) |
| 2026-09-22 | GMF Bristol LLC | Other Real Estate | D | $1.1M | Indefinite | Rule 506(b) |
| 2026-09-22 | DV Member, L.L.C. | Pooled Investment Fund | D | $0 | $5.3M | Rule 506(b), Investment Company Act 3(c), 3(c)(1), 3C.5 |
| 2026-09-22 | Bristol Denville, LLC | Commercial | D | $140K | $8.6M | Rule 506(c) |
| 2026-09-22 | Lightcone Venture Capital I LP | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1), 3(c)(7) |
| 2026-09-21 | Functional Longevity Labs, Inc. | Other Health Care | D | $25K | $1.0M | Rule 506(b) |
| 2026-09-21 | Monocacy Therapeutics Inc. | Biotechnology | D | $49 | $49 | Rule 506(b) |
| 2026-09-18 | Amiricon Phoenix Fund I, LLC | Commercial | D | $0 | $2.0M | Rule 506(c), Investment Company Act 3(c), 3(c)(1) |
| 2026-09-18 | Latitude Ventures Kalshi II a series of Allocations 2026 Master, LLC | Pooled Investment Fund | D/A | $11.5M | $11.5M | Rule 506(b), Investment Company Act 3(c), 3(c)(1) |
| 2026-09-18 | SCP Real Estate Opportunity XI LP | Pooled Investment Fund | D | $0 | $1.5M | Rule 506(b) |
| 2026-09-17 | Throne Labs, Inc. | Other | D | $14.1M | $15.0M | Rule 506(b) |
| 2026-09-17 | Gliknik Inc | Biotechnology | D/A | $15.0M | $15.0M | Rule 506(b) |
| 2026-09-17 | Expect Equity Onshore Fund II LP | Pooled Investment Fund | D/A | $10.8M | Indefinite | Rule 506(c), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-17 | Expect Equity Offshore Fund II LP | Pooled Investment Fund | D/A | $40.0M | Indefinite | Rule 506(c), Investment Company Act 3(c), 3(c)(7) |
Median minimum investment accepted, among the 11 notices above that report one: $75,000.
Query these notices
The Form D offerings endpoint returns every notice for a quarter with all issuer identities and source strings. Filter by issuer CIK, or page through a quarter and group by industry or location yourself.
curl "https://sec-api.dev/api/v1/offerings?period=2026q3&limit=25" \
-H "Authorization: Bearer $SEC_API_KEY"Questions
How many Form D filings came from Maryland?
339 Form D notices were filed by issuers based in Maryland in Q2 2026 and Q3 2026, 260 new and 79 amendments. 92.6% claimed Rule 506(b) and 7.1% Rule 506(c).
Does amount sold equal money raised this quarter?
No. The total amount sold on a notice is cumulative for the offering. Use new notices, or the latest amendment per offering, to avoid double counting.
Other locations
Plain-text version for agents and LLMs: /form-d/locations/maryland.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.